(Q41500212)

1 October 2017

1 reference

title

The potential impact of the varicella vaccine and new antivirals on ocular disease related to varicella-zoster virus (English)

1 reference

1 October 2017

J S Pepose

1

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

American Journal of Ophthalmology

1 October 2017

published in

1 reference

1 October 2017

volume

123

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

243-251

1 reference

Selective decline in cellular immune response to varicella-zoster in the elderly

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Immune responses to varicella-zoster in the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Varicella-zoster virus: History, perspectives, and evolving concerns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Population-based study of herpes zoster and its sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Racial differences in the occurrence of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Observations on the natural history of herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Complications of herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Herpes zoster optic neuritis in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Varicella zoster virus is a cause of the acute retinal necrosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Diagnosis and management of the acute retinal necrosis (ARN) syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Association of varicella zoster dermatitis with acute retinal necrosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Oral acyclovir in herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Oral acyclovir for herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Acyclovir and post-herpetic neuralgia and ocular involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Treatment of the acute retinal necrosis syndrome with intravenous acyclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Antiviral sensitivities of the acute retinal necrosis syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Successful treatment of rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Treatment of outer retinal necrosis in AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Sorivudine: a promising drug for the treatment of varicella-zoster virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Successful treatment of sorivudine-related agranulocytosis with granulocyte-colony stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Treatment of progressive outer retinal necrosis with sorivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Foscarnet-resistant multidermatomal zoster in a patient with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Live vaccine used to prevent the spread of varicella in children in hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Varicella Dendritic Keratitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Ocular manifestations of the congenital varicella syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Herpes zoster in a normal child after varicella vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

Acute retinal necrosis syndrome following herpes zoster dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971042-6

7 January 2021

10.1016/S0002-9394(14)71042-6

Identifiers

DOI

1 reference

release_iz7habo2ofb4fjd2an6yfhrn4a

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iz7habo2ofb4fjd2an6yfhrn4a

24 November 2022

mapped directly with Wikidata item

1 reference